Analytical and Microbiological support Case Study
UK Clinical Research Unit (CRU), developing intravenous (IV) products in need of analytical & microbiological support
Analysis of Insulin Analogues Case Study
European biotech company developing an NCE to fulfil an unmet patient need, required insulin analogue analysis to gain regulatory approval
Drug Substance Salt Selection Case Study
US Biopharmaceutical seeking drug substanceand salt screen selection for their molecule.
Global Clinical Trial Supplies
Quotient can ease the headache of global product supply logistics and accelerate your proof-of-concept timeline. We’ll develop and manufacture your drug product, and then seamlessly integrate into a flexible packaging, labelling & distribution strategy, tailored to your clinical trial.
The Integration of Drug Substance and Drug Product
This webinar highlights how a fully integrated program can speed up transition from candidate selection to proof of concept and shorten the pathway to clinical development.
Application of Translational Pharmaceutics in Accelerating the Development of MR Dosage Forms
Poster presentation at NERDG 2021 Annual Meeting. In this poster we demonstrate an optimized approach to developing oral modified-release (MR) dosage forms using the Translational Pharmaceutics platform. This approach uses emerging human data to inform adjustment of formulation composition in an adaptive clinical study.
Flexible strategies for getting drug product to patients
This webinar from Quotient Sciences will explore the existing challenges of managing the manufacture and distribution of clinical trial supplies to numerous sites, in multiple countries, and discuss how to streamline your clinical trial supply chain and accelerate your proof-of-concept timeline.
Accelerating molecules through to Proof-of-Concept, with an integrated early development program
This webinar highlights how a fully integrated development plan can bring together the needs of the drug product team and the clinical development team.
Flow Chemistry for Accelerated Drug Substance Delivery
This webinar discusses drug substance manufacturing in early development and the very concept of being fast, agile and innovative.
Formulation strategies for poorly soluble molecules - Pharmaceutics and biopharmaceutics considerations
This presentation uses expert insight and case studies to explore formulation and solubility challenges and discuss the best strategies and technologies for advancing poorly soluble molecules, to deliver success.
Risk Based Monitoring from a Phase I Clinical Site Perspective
Risk-Based Site Monitoring (RBSM) has been developed as an effective approach to overseeing clinical trials without compromising ethics, volunteer safety, data integrity, quality, timelines, and regulatory compliance. This approach is based on risk assessment, mitigation and, when possible, the removal of risks allowing the allocation of the resources in the activities where they are needed the most.